We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction.
- Authors
Lamberti, A.; Lora, V.; Graceffa, D.; Bonifati, C.; Cota, C.
- Abstract
I Editor i After the onset of the pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) affected tens of millions of people, with devastating medical, social and economical consequences. 9 Ricardo JW, Lipner SR. Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine. According to clinical and histopathological findings, considering the temporal relationship with vaccine administration, we diagnosed her with nail psoriasis associated with Pfizer/ BioNTech (BNT162b2) COVID-19 vaccine.
- Subjects
NAIL diseases; COVID-19 vaccines; SARS-CoV-2
- Publication
Journal of the European Academy of Dermatology & Venereology, 2022, Vol 36, Issue 10, pe745
- ISSN
0926-9959
- Publication type
Article
- DOI
10.1111/jdv.18255